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Harnessing the wisdom of crowds 
can improve guideline compliance 
of antibiotic prescribers 
and support antimicrobial 
stewardship
Eva M. Krockow1*, R. H. J. M. Kurvers2, S. M. Herzog2, J. E. Kämmer2,3, R. A. Hamilton4, 
N. Thilly5, G. Macheda5 & C. Pulcini5
Antibiotic overprescribing is a global challenge contributing to rising levels of antibiotic resistance 
and mortality. We test a novel approach to antibiotic stewardship. Capitalising on the concept of 
“wisdom of crowds”, which states that a group’s collective judgement often outperforms the average 
individual, we test whether pooling treatment durations recommended by different prescribers can 
improve antibiotic prescribing. Using international survey data from 787 expert antibiotic prescribers, 
we run computer simulations to test the performance of the wisdom of crowds by comparing three 
data aggregation rules across different clinical cases and group sizes. We also identify patterns of 
prescribing bias in recommendations about antibiotic treatment durations to quantify current levels 
of overprescribing. Our results suggest that pooling the treatment recommendations (using the 
median) could improve guideline compliance in groups of three or more prescribers. Implications for 
antibiotic stewardship and the general improvement of medical decision making are discussed. Clinical 
applicability is likely to be greatest in the context of hospital ward rounds and larger, multidisciplinary 
team meetings, where complex patient cases are discussed and existing guidelines provide limited 
guidance.
Antimicrobial overuse is widespread and presents a major public health threat. It promotes the emergence of 
drug-resistant infections, which—without action—are predicted to incur annual costs of more than 10 million 
lives by 2050, more than all cancer deaths  combined1. A particular type of drug resistance, termed antimicro-
bial resistance (AMR), refers to adaptations of the biological functions of microbes such as bacteria, which can 
render them less or non-susceptible to antibiotic drugs, meaning that bacterial infections become difficult or 
even impossible to treat. While AMR develops naturally, the use of antibiotics accelerates this  process2. In most 
countries, antibiotic use is legally regulated and requires prescription from a medical  professional3, yet prescribing 
choices often fail to meet international guidelines. Current evidence suggests that around 30–40% of antibiotic 
prescriptions for hospital  patients4,5 and up to 60% of antibiotic prescriptions in primary  care6 are inappropriate, 
although it has to be acknowledged that inappropriate prescribing is often context-dependent and measuring 
it thus presents a  challenge7. To improve antibiotic use and preserve drug effectiveness for future generations, a 
crucial step is therefore to support doctors in their decision making and encourage guideline adherence to curb 
inappropriate prescribing.
Inappropriate prescribing can manifest itself in different ways. Examples include (1) prescribing antibiot-
ics when they are medically not required (e.g., for viral infections), (2) prescribing an inappropriate type of 
antibiotics (e.g., broad-spectrum instead of narrow-spectrum antibiotics), or (3) prescribing antibiotics for an 
inappropriate length of  time8. With regard to treatment duration, it is probable that longer durations promote 
the risk of AMR. Nevertheless, many prescribers consistently deviate from shorter treatment recommendations 
and prescribe longer courses of antibiotics than  necessary9.
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The reasons for overprescribing are manifold—particularly when it comes to choosing appropriate treatment 
 durations10. Lack of awareness of existing recommendations and outdated habits based on previous guidelines 
are a common problem. For example, many prescribers continue to believe that short or unfinished courses of 
antibiotics may drive resistance, thus prescribing medication for longer than  necessary11. Additionally, a key 
reason for the overprescribing of antibiotics is the concern with individual patient risks associated with bacterial 
infections. Medical doctors typically strive to minimise their patients’ health risks due to an intrinsic motivation 
to protect the individuals under their care and to avoid litigation or damage to their professional  reputation8. 
Hence, in the clinical context, the interests of individual patients often loom larger than the long-term interests 
of society, which typically include protecting antibiotic drug effectiveness for many generations. Given these 
strategic properties, antibiotic prescribing has been conceptualised as a challenging social  dilemma12,13, which 
may require special decision mechanisms to protect the collective interests and preserve antibiotic effectiveness.
Most previous interventions to curb overprescribing of antibiotics, including unnecessarily long treatment 
durations, focused on improving the education and training of prescribers or regulating access to antimicro-
bials. However, considering the mixed results of these interventions’  effectiveness14, alternative or additional 
approaches need to be considered to improve prescribers’ decisions to prescribe an antibiotic treatment and 
shorten prescribing durations. Relevant research on the improvement of decision accuracy has been conducted 
in the field of judgement and decision making. One approach includes collecting individual judgements of 
members belonging to a larger group of decision makers and aggregating these judgements to derive a final, 
group-based choice.
In line with the popular proverb “two heads are better than one”, the combined knowledge and intelligence 
of groups, which is also referred to as the “wisdom of crowds” (WoC) or “collective intelligence”, can often pro-
duce better choices than individual  ones15. WoC describes the phenomenon that the aggregated judgement of 
a group of people is typically better than the judgement made by a randomly drawn member of the  group16–19. 
The surprising accuracy of WoC is typically attributed to a crowd’s diversity of errors, which cancel out when 
 combined17,18. Crucially, WoC depends on the independence of each crowd member’s opinion. It is therefore dif-
ferent from team-based decision making, where group members discuss their judgements before reaching a joint 
decision. Indeed, WoC may offer particular benefits in situations characterised by hierarchical social structures 
(e.g., hospitals contexts with professional distinctions between doctors, nurses and pharmacists), which could 
affect more traditional team work by discouraging participation of more junior team  members16.
Empirical evidence shows that WoC approaches may improve decision accuracy across many abstract experi-
mental tasks, including general knowledge  tests20, memory  tasks21 and combinatorial  problems22. Additionally, 
a growing number of studies have demonstrated the potential of WoC in more applied contexts of medical deci-
sion  making23–27. A recent computer-simulation  study28, for example, suggested that medical students’ diagnoses 
for acute medical patients could be improved through an aggregation of two or more opinions. Despite these 
promising results, the aggregation of group judgements remains a novel approach within the healthcare sec-
tor, and requires further testing in the context of specific medical decision problems. With regard to antibiotic 
prescribing, some studies investigated interactive decision processes of multi-disciplinary treatment teams, and 
found that the joined judgements of diverse groups of health professionals (e.g., including microbiologists and 
pharmacists) could improve guideline compliance and cut medication  costs29–31. However, no research to date 
has assessed the benefits of non-interactive judgement aggregation of antibiotic prescribing decisions based on a 
WoC approach. Given the urgent global need of effective antibiotic stewardship, WoC could offer a new approach 
to addressing the complex issue of overprescribing.
To harness WoC for solving specific decision-making problems, the judgements of all crowd members are 
collected and aggregated according to a pre-defined crowd rule. Which crowd rule is applicable and performs 
best depends on the task at  hand18. For example, while numeric responses can be aggregated using crowd rules 
such as the arithmetic mean or median, categorical responses require a different approach (e.g., choosing the 
most frequent response).
In the following, we provide the first application of WoC theory to the problem of antibiotic decision making. 
Specifically, we investigate whether WoC can improve decisions about antibiotic treatment durations. Drawing 
on existing survey data containing choices about antibiotic prescription durations made by 787 medical profes-
sionals across 15 patient  vignettes9, we will test three main research questions.
1. Can WoC help to improve prescribers’ compliance with international guidelines?
2. What WoC conditions (e.g., group size and crowd rule) are most effective in achieving prescriber compli-
ance?
3. What are the underlying patterns of prescribing bias?
Methods
Our analyses are based on previous survey  results9 (raw data were obtained from the original authors), which 
assessed prescriber choices of antibiotic treatment durations for 15 hypothetical clinical scenarios (vignettes). 
Below, we briefly describe the original data collection and sample before detailing our own study design.
Materials and procedure. The original study used an electronic questionnaire consisting of a section on 
participant details (e.g., age, professional role and country of residence), and survey questions about antibiotic 
prescribing choices. The full questionnaire can be found in the supplemental materials of the original  article9. 
Specifically, participants were asked to consider a sequence of 15 clinical vignettes, all of which involved bacte-
rial infections. For each vignette, they were required to make a recommendation of treatment duration based 
on their regular practice (usual recommendations they make to clinicians outside their home department when 
3
Vol.:(0123456789)
Scientific Reports |        (2020) 10:18782  | https://doi.org/10.1038/s41598-020-75063-z
www.nature.com/scientificreports/
advising them). An overview of the different vignettes and descriptive statistics of participants’ treatment recom-
mendations is presented in Table 1.
Participants. The empirical data were collected between September and December  20169. The study was 
uncompensated and advertised in newsletters of professional medical networks including ESCMID (European 
Society of Clinical Microbiology and Infectious Diseases) and SPILF (Société de Pathologie Infectieuse de 
Langue Française, the French Infectious Diseases society). The sample consisted of expert antibiotic health pro-
fessionals (e.g., microbiology or infectious diseases specialists), who advised clinicians on antibiotic use at least 
once per week outside their home department. Following the deletion of participants who had failed to provide 
any responses to the 15 vignettes, we obtained a data set of 787 participants (417 males and 365 females, five par-
ticipants did not disclose their sex) out of 1053 who participated in the original survey. Thirty-seven participants 
were under the age of 30, 504 ranged between 30 and 50 years, 243 were older than 50, and three participants 
did not disclose their age. The majority of professionals had ten or more years of professional experience. While 
the sample included participants from 57 countries, most participants were recruited from countries in Western 
Europe including 156 from France, 128 from the UK, 75 from Spain and 69 from Germany. A detailed overview 
of sample characteristics is included in the original survey  publication9.
Design. We used descriptive statistics to characterise prescribing patterns and ran computer simulations to 
explore the potential of WoC to increase the number of prescribing recommendations in line with international 
guidelines (see below for details) and to decrease the prescribing error per vignette. The simulations involved 
randomly creating prescriber groups from previous survey  results9, with group sizes ranging between three and 
19 prescribers. Prescribers with missing values for the vignettes in question were omitted from the randomly 
created groups and missing cases were filled up with a new randomly drawn person. A maximum group size of 
19 was chosen because even though regular ward rounds usually involve group sizes of five physicians, multidis-
ciplinary team meetings typically involve 10–15 and might even achieve participant numbers up to 19 depend-
ing on the topic, meeting objective and the hospital size. Larger group sizes of doctors are, however, unfeasible 
given typical staffing constraints in most healthcare settings. For each group size, we ran different simulations of 
data aggregation based on three different crowd rules discussed below. For each group size and crowd rule, we 
ran 10,000 repetitions. A visual overview of our procedure is presented in Fig. 1.
Crowd rules. The effectiveness of different crowd rules for numeric responses depends on the presence and 
direction of bias in the population from which the groups are drawn (e.g., over- vs. underestimation). Sym-
metrically distributed errors, leading to similar amounts of over- and  underestimation20,32,33, are best reduced 
by averaging rules that combine the individual judgements using a central, univariate moment (e.g., arithmetic 
mean or median). In contrast, in the presence of substantial population bias (i.e., systematic differences between 
the population average and the correct answer), the performance of crowd rules, such as the mean, is limited by 
the size of the population bias because such rules, by design, approximate the population bias. Here, different 
approaches are needed that consider the direction and size of the population bias (e.g., calculating a specific per-
centile, such as the first quartile of a sample of judgements). In the context of antibiotic prescribing, for example, 
it is paramount to distinguish between prescribing errors that resulted from overprescribing and underprescrib-
ing, respectively.
We tested three different crowd rules to aggregate individual decisions. The first two rules involved following 
either the mean or the median response, which represent two standard techniques for averaging judgements. 
The third rule involved following the sample’s lower (i.e., first) quartile.
1. The “Follow-the-mean” rule (F-Mean), involved calculating the mean of all group members’ individual 
responses and rounding to the nearest integer.
2. The “Follow-the-median” rule (F-Med) involved calculating the median (50th percentile) for all group mem-
bers’ responses and rounding to the nearest integer. Since the number of prescription days is bounded below 
(i.e., minimum prescription length is 0 days), we can expect that the distribution of days is right skewed. 
Hence, the median is expected to result in lower prescription recommendations than the arithmetic mean 
and thus in lower levels of overprescribing.
3. The “Follow-the-lowest-quartile” rule (F-Quart) involved calculating the lower (i.e., first) quartile (25th 
percentile) for all group members’ responses and rounding to the nearest integer. For this rule, a minimum 
group size of four was required, so results will not be displayed for the smallest group size of 3. This rule was 
included with the specific aim to address the frequently observed bias towards overprescribing.
Data analysis. To assess the accuracy of prescribing choices, we compared individual responses and the 
outcomes of each crowd rule simulation against the combined recommendations of infection-specific prescrib-
ing durations issued by the Infectious Diseases Society of America (IDSA) and SPILF. The guidelines of these 
internationally leading organisations on infectious diseases are evidence-based and are widely accepted in the 
US and in France, and to a lesser extent in other countries when national guidelines are not available, and 
form the basis of many local hospital guidelines. Acknowledging that these guidelines are not the standard in 
all countries worldwide, for the purpose of this exploratory study we used their treatment recommendations 
to define a range of appropriate treatment durations for antibiotic prescribing. For most vignettes, both IDSA 
and SPILF treatment recommendations entailed a range of possible durations, marked by a lower and an upper 
bound (see Table 1). In particular, for the lower bound we used the smaller of the two lower bounds (IDSA or 
SPILF) and for the upper bound we used the larger of the two upper bounds (IDSA or SPILF). For one third 
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Table 1.  Overview of clinical vignettes, treatment recommendations and descriptive statistics for participants’ 
choices of treatment durations. IDSA Infectious Diseases Society of America, SPILF Société de Pathologie 
Infectieuse de Langue Française, the French Infectious Diseases society.
No.
Brief description of 
vignette
Prescribing durations recommended by 
IDSA/SPILF guidelines Participants’ choices of treatment durations
Lower bound (days) Upper bound (days)
Number of 
responses
Mean prescribing 
choice (days)
Standard deviation 
(days)
Median prescribing 
choice (days)
Prescribing range 
(days)
V1
Child or teenager 
with meningococcal 
meningitis
5 7 689 8.19 7.22 7 0–180
V2
Patient with acute 
cholangitis, success-
fully and rapidly 
treated by endoscopic 
biliary drainage
3 3 736 6.81 3.50 7 0–49
V3
Patient with diffuse 
peritonitis (after 
surgery with an early 
adequate source 
control)
4 7 744 7.46 3.72 7 0–49
V4
Uncomplicated 
pyelonephritis in an 
adult woman (if a 
fluoroquinolone is 
prescribed)
5 7 759 7.34 2.28 7 0–21
V5
Complicated acute 
pyelonephritis in an 
adult woman
10 14 752 12.09 3.83 14 1–60
V6
Patient presenting an 
acute exacerbation of 
a severe COPD
5 5 726 6.19 3.37 7 0–60
V7
Outpatient with 
an uncomplicated 
pneumonia
5 7 754 6.61 2.24 7 0–49
V8
Patient presenting 
an uncomplicated 
catheter-related 
Staphylococcus aureus 
bacteraemia (without 
endocarditis and with 
early removal of the 
catheter), after nega-
tive blood cultures
14 14 752 11.93 4.51 14 2–49
V9
Uncomplicated 
catheter-related Kleb-
siella pneumoniae 
bacteraemia (with 
early removal of the 
catheter)
7 14 747 9.00 4.86 7 0–90
V10
Uncomplicated 
Escherichia coli ver-
tebral osteomyelitis 
in a patient without 
orthopaedic implant
42 42 725 43.61 20.53 42 0–180
V11
Patient present-
ing a diabetic foot 
infection, with bone 
infection, not eligible 
for surgery
42 84 665 48.63 30.07 42 0–180
V12
Patient with an 
uncomplicated 
staphylococcal pros-
thetic joint infection, 
managed with 1-stage 
exchange
42 84 648 57.95 35.17 42 0–365
V13
Patient presenting 
with an uncompli-
cated (streptococcal) 
erysipelas
5 7 703 8.06 2.89 8 3–42
V14
A child (2 years old) 
with a first episode of 
acute otitis media
5 5 557 4.72 3.19 5 0–14
V15
An adult with an 
uncomplicated 
bacterial maxillary 
sinusitis
5 7 693 6.86 3.68 7 0–28
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of the vignettes (V2, V6, V8, V10 and V14), IDSA and SPILF recommendations specified a single appropriate 
treatment duration instead of a range. For these, we recorded the upper and lower bounds as identical (i.e., the 
single recommended duration).
We calculated three types of accuracy. (1) We coded each response that fell within the recommended range 
of the respective vignette as a “hit” (i.e., indicating a correct response, compliant with the guidelines). Then we 
calculated the “hit rate”, that is, the proportion of vignettes for which a correct prescribing choice was made. (2) 
To capture over- vs. underprescribing, we calculated for each response a “signed error”, that is, by how many 
days the response either overshot the upper bound (coded as a positive error) or undershot the lower bound of 
the respective range (coded as a negative error); for hits, we coded the error as zero. Hence, a positive signed 
error indicates overprescribing and a negative signed error underprescribing. Because vignettes ranged widely 
in their recommended duration (Table 1), we standardised the signed error—to facilitate comparing and sum-
marising across different vignettes—by dividing each value by the centre of the respective recommended range 
of that vignette (i.e., the arithmetic mean of the lower and upper bound), yielding a “standardised signed error”. 
Summarising several such values using the arithmetic mean gives the “mean standardised signed error” or, in 
short, the “standardised bias”, which captures any systematic tendency to over- or underprescribe. (3) To capture 
the magnitude of prescription errors (i.e., irrespective of whether they represent over- or underprescribing) 
we calculated the “absolute standardised error”, that is, the magnitude of the standardised signed error (i.e., its 
absolute value, ignoring the sign). Averaging several such values gives the “mean standardised absolute error” 
or, in short, the “standardised error”.
Results
Figure 2a,b shows the average hit rates and standardised error for different group sizes and crowd rules, aver-
aged across all 15 vignettes. To improve legibility of the results, only odd-numbered group sizes are shown. The 
different crowd rules varied in their success in improving decision making about antibiotic treatment durations 
compared to the average individual prescribing duration. Two out of three crowd rules (F-Med and F-Quart) 
showed marked improvements in hit rates compared to the data of individual prescribers. All three crowd rules 
led to noticeable decreases in standardised error. Overall, the most successful rule was F-Med (Fig. 2a,b). Indeed, 
the hit rate already showed a noticeable increase at a group size of only three decision makers. With increasing 
group sizes, an almost strict increase of hit rate and an almost strict decrease in standardised error was found. 
Figure 2c shows the standardised signed error for individual prescribers (i.e., group size n = 1) across all vignettes. 
Almost two thirds of prescribing choices had a standardised signed error of 0 and were, therefore, fully compliant 
with the IDSA and SPILF guidelines (Fig. 2c). Comparing the distributions to the left and right of the 0 value, 
we observe a larger proportion of the distribution on the right hand side (i.e., positive values), reflecting the 
overall tendency to overprescribe.
Next, we present results specific to each vignette. As shown in Fig. 2a,b, the WoC approaches were mostly suc-
cessful in improving guideline compliance compared to the treatment choices by individual prescribers. However, 
Fig. 3 demonstrates that their effects varied across vignettes (again, only the results for odd-numbered group 
sizes are shown). F-Med was highly successful in increasing hit rates for all vignettes apart from Vignette 2 (acute 
cholangitis), Vignette 6 (acute exacerbation of a severe COPD) and Vignette 13 (uncomplicated streptococcal 
erysipelas). Neither F-Mean nor F-Quart (Figs. 2 and 3) performed consistently well in improving guideline 
compliance of prescribers. Indeed, Fig. 3a demonstrates that, for some vignettes (most notably V1, V8, V10 and 
V13), hit rates of F-Mean and in some cases F-Quart decreased as group size increased.
Figure 1.  Procedure of wisdom of crowds group simulations. IDSA Infectious Diseases Society of America, 
SPILF Société de Pathologie Infectieuse de Langue Française, the French Infectious Diseases society.
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Finally, Fig. 4 presents the standardised signed error for individual prescribers across the 15 vignettes. With 
the exception of Vignette 2 (acute cholangitis), the most frequent value for each vignette was 0, indicating that 
the majority of prescribers chose prescribing durations compliant with the IDSA and SPILF guidelines. Vignette 
2 and to a lesser extent Vignettes 6 (acute exacerbation of a severe COPD) and 13 (uncomplicated streptococ-
cal erysipelas) showed a stronger bias towards overprescribing, with 82%, 46% and 45% of treatment recom-
mendations, respectively, falling above the recommended duration. In the case of Vignette 2, most treatment 
recommendations had a standardised signed error of either 0.67 or 1.33, which corresponds to prescribing 5 
and 7 days, respectively.
Discussion
Our study presents the first application of a WoC approach to the area of antibiotic decision making, thus offering 
a novel combination of the research on judgement and decision making and the fields of health-related behaviour 
change and antibiotic stewardship. Re-analysing an extant data set of prescriber choices for antibiotic treatment 
durations in the context of 15 medical case  vignettes9, we used computer simulation to randomly create groups 
ranging between three and 19 prescribers. Following the recommendations of established antibiotic prescribing 
guidelines (IDSA and SPILF), we subsequently tested whether the aggregated group choices could improve treat-
ment decisions compared to those of individual prescribers. We compared three crowd rules—“Follow-the-mean” 
(F-Mean), “Follow-the-median” (F-Med) and “Follow-the-lowest-quartile (F-Quart)—and found evidence for 
the success of aggregating group decisions to improve guideline compliance. The most successful crowd rule 
was F-Med, which calculated the median prescribing duration (rounded to the closest integer) for each group 
of prescribers. It improved guideline compliance by increasing hit rates and decreasing the standardised error 
for 80% of the vignettes. While best guideline compliance was achieved with our maximum group size of 19 
prescribers, F-Med produced improvements of both hit rate and standardised error for group sizes of as little as 
three prescribers. F-Med outperformed F-Mean and F-Quart, both of which produced mixed results.
In fact, a peculiar phenomenon was observed for some vignettes in the context of F-Mean and F-Quart. A 
number of vignettes (e.g., V1, V8, V10, and V13) showed a decrease in hit rate as group size increased. A possible 
explanation is that as group size increases, the crowd rule output becomes less variable; in the extreme case of 
using the whole population, the crowd rule will always output the same collective judgement (by necessity). If 
the population is unbiased, then having less variance (as group size increases) is of benefit, because the crowd’s 
judgement is increasingly more likely to land near the population average and thus to be within the range of 
appropriate prescribing. However, for vignettes with noticeable bias, low variance is—somewhat ironically—a 
disadvantage, because with increasing group size it becomes increasingly unlikely that the crowd judgement 
will—by sheer luck (i.e., sampling error)—land within the correct range.
A reason for the comparative success of F-Med, is the robustness of the  median34,35, which can be explained 
by its high “breakdown point”. This measure refers to the proportion of observations that would need to be 
moved into the same direction (e.g., higher value) so that the estimator (e.g., the median) starts to move itself. 
For the median this breakdown point is 50%, which means that more than half of the chosen antibiotic prescrib-
ing durations would need to move in the same direction (either all over- or all underprescription) before the 
median starts to shift. By comparison, the mean is much more easily influenced and can be distorted by a single 
extreme response.
Despite the overall success of F-Med, however, three exceptions were identified amongst the 15 vignettes 
used in the antibiotic prescribing survey: Vignettes 2 (acute cholangitis), 6 (acute exacerbation of a severe 
COPD) and 13 (uncomplicated streptococcal erysipelas). Vignette 2 showed no improvement in either hit rate or 
standardised error when individual choices were aggregated at the group level. To a lesser extent, Vignette 6 and 
Vignette 13 were also exceptions. At a maximum group size of 19 decision makers, their likelihood of choosing 
Figure 2.  Comparison of (a) average hit rates and (b) standardised error for the three crowd rules (averaged 
across all 15 vignettes) for varying group sizes. The x axes display the group sizes, and the y axes show average 
hit rates (ranging from 0 to 1) and the standardised error, respectively. The dotted lines represent the average hit 
rate and standardised error for the data of individual prescribers (group size of n = 1). (c) Shows the standardised 
signed error for individual prescriber data (group size n = 1) pooled across all vignettes.
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Figure 3.  Comparison of hit rates and standardised error for the three crowd rules for varying group sizes per 
vignette (1–15). The x axes display the group sizes, and the y axes show (a) hit rates (ranging from 0–1), and (b) 
standardised error. Note that for Vignette 2 the standardised error exceeded 0.5 (the upper bound of the plotted 
y-axis); see Supplementary Fig. 1 for the full results of Vignette 2.
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a guideline-compliant treatment duration was only around 50%. The poor performance of F-Med in the context 
of these vignettes could be attributed to the particularly high levels of overprescribing found in the individual-
level data. This is in contrast with most other vignettes, which showed more equal proportions of under- and 
overprescribing. The biased distributions for Vignettes 2, 6, and 13 likely rendered these contexts unsuitable to 
averaging techniques such as calculating the median. Consistent with this claim, the F-Quart rule—which by 
design corrects for overprescribing—outperformed F-Med for these three vignettes.
The reason for variations in the patterns of over- vs. underprescribing in the individual-level responses, 
however, is more difficult to explain. The large levels of overprescribing in Vignettes 2, 6 and 13 may have been 
due to participants’ misunderstanding the clinical scenario described by the vignette. Another, perhaps more 
likely, possibility is that the IDSA and SPILF guidelines for these vignettes are less established, thus accounting 
for a general lack of knowledge about appropriate treatment durations. Indeed, it is important to note that only 
limited research on optimal prescribing durations has been conducted to date, leaving antibiotic treatment dura-
tions open to  debate36. Recent clinical trials, for example, have suggested that traditional courses of antibiotics 
could be shortened without compromising patient  safety37, 38, but this latest evidence has not yet been translated 
into guidelines. Hence, even though IDSA and SPILF guidelines are used widely internationally, their recom-
mendations are by no means  undisputed39,40. This also leaves prescribers more vulnerable to behavioural biases. 
In the case of Vignette 2, for example, a closer analysis of the participants’ choices demonstrated a bias towards 
the prescription of treatments with durations of either 5 or 7 days (or multiples thereof). This 5/7-day bias has 
previously been reported in the context of antibiotic  prescribing40–43 and is likely due to an inherent cultural ten-
dency to use simple units of measurement (e.g., five fingers per hand and 7 days per week), which simultaneously 
serves as a memory aid. While the bias may not always present a problem, it could be particularly damaging in 
the cases of short-term bacterial infections, which can be treated successfully with only 2 or 3 days of medication.
Given our identification of several exceptions in the clinical cases considered for our analysis, it is important 
to identify and predict criteria of future patient cases that make them suitable for a WoC approach and specifically 
the “Follow-the-median” rule, which was found to be the most successful rule for the current data set. Qualita-
tive follow-up research (e.g., based on verbal protocol analysis) could explore the individual decision-making 
processes for the 15 original vignettes or additional patient cases in more depth and thereby identify indicators 
that either increase or decrease the applicability of WoC approaches to specific clinical decision dilemmas. A 
consequently increased understanding of the reasoning processes underlying recommendations for prescribing 
durations could enable the more targeted application of WoC data aggregation methods.
Our results have important implications for the field of medical decision making and, in particular, the 
challenging task of antibiotic stewardship. Previous behaviour change interventions to decrease unnecessary 
Figure 4.  Standardised signed error per vignette when following combined IDSA and SPILF guidelines on 
prescribing durations. The x axes show the standardised signed error, with 0 indicating that the response fell 
within the appropriate prescribing range (i.e., no over- or underprescribing). A negative (positive) x-value 
indicates underprescribing (overprescribing). The y axes show the percentage of responses for each value of 
standardised signed error.
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antibiotic prescribing relied on either restrictive techniques to deter overprescribing of antibiotics or persuasive 
approaches to encourage a more conscious decision process guided by better information about the recom-
mended diagnostic and therapeutic decision process and the societal risk of AMR. Unfortunately, the effective-
ness of these approaches  varied14,44. Against this background, our evidence for the potential of crowd-based 
decision making without the need of introducing large-scale educational programmes is highly promising.
In addition to improved prescribing, the WoC approach provides another potential benefit. Group-based 
judgements could make an important contribution towards relieving individual doctors from patient pressures 
and fears of litigation. Previous  literature8 has highlighted the prescribers’ common worry about poor patient 
outcomes, which often leads them to err on the side of overprescribing antibiotics. Introducing WoC-based 
procedures for making treatment decisions could be an important step towards diffusing individual prescriber 
responsibility and providing a more protected decision environment with less contextual drivers of overpre-
scribing. Follow-up research is needed to test this additional benefit in real-life clinical decision contexts and 
investigate the wider applicability of WoC-based aggregation techniques.
Addressing other aspects of antibiotic decision making. The present study focused on prescriber 
decisions about the durations of antibiotic treatment. This had the benefit of being able to draw on a set of 
numeric interval data, thus allowing for a variety of different mathematical crowd rules to be tested. However, 
the problem of antibiotic overprescribing is not limited to excessive prescribing durations. Additional challenges 
include, for example, misguided choices to prescribe antibiotics in the absence of bacterial infections or choices 
to prescribe inappropriate types of  antibiotics8. Both of these cases of inappropriate prescribing are examples of 
a different problem format, which requires categorical responses from the decision maker rather than numerical 
ones. A consequence of the different format is that applicable crowd rules are likely to differ. In fact, none of the 
crowd rules investigated in the current study would translate to a categorical problem format. Future research 
therefore needs to test the applicability of WoC in the context of other antibiotic decision aspects and identify 
what crowd rules and group sizes are most helpful for improving decision making in those situations.
Studying a variety of prescriber samples. The current study was conducted using a sample of infection 
experts (e.g., microbiologists or infectious disease specialists), who regularly give advice to less experienced col-
leagues. It is therefore likely that the overall performance of our sample was higher (i.e., better guideline compli-
ance and overall shorter prescribing durations) than what could be expected from a mixed sample of frontline, 
non-specialist prescribers. It is possible that overprescribing is more frequent in samples with lower expertise in 
the field, thus necessitating a more conservative crowd rule like F-Quart to compensate for this selection bias. 
To investigate such differences, more research is needed on prescribing patterns of different sub-populations of 
health professionals.
Maximising real‑life applicability. An important prerequisite for more applied research on WoC in clini-
cal decision making is to identify real-life choice contexts that fulfil the key assumptions of WoC and thus pro-
vide a suitable decision environment to enable successful WoC applications. The main assumption outlined in 
the Introduction is a diverse crowd of decision makers with independent judgement  errors18,45. Below, we discuss 
this assumption in the context of three common prescribing contexts: outpatient consultations, hospital ward 
rounds, and multidisciplinary team meetings.
Outpatient consultations. Outpatient appointments are typical for the primary care sector as well as treatment 
of long-term, non-acute patients in secondary and tertiary care. Appointments are typically led by single clini-
cians. Given the hectic and pressurised choice environments of many clinical healthcare  settings46,47, individual 
prescribers are frequently pressed to make instantaneous choices that prevent them from consulting colleagues. 
The feasibility of consulting “crowds” of decision makers in such outpatient consultations is therefore ques-
tionable. Rather than aggregating different prescriber opinions in real-time, other physicians’ antibiotic choices 
could be discussed as retrospective multidisciplinary team and case-review meetings, or be recorded and com-
municated to those who frequently overprescribe. Previous research has confirmed the potential of providing 
such feedback in primary  care10.
Ward rounds. Hospital ward rounds are routinely conducted by medical teams consisting of around three 
to five medical staff (consultants, junior doctors, and students), pharmacists, nurses, and allied-health profes-
sionals. Given that our results show that WoC can improve decisions about antibiotic treatment durations in 
groups as small as three decision makers, ward rounds could provide viable settings to trial WoC-based deci-
sion aggregation and compare its effectiveness with decisions reached through joint team discussions. A poten-
tial challenge in smaller groups are disproportionate influences of senior group members. In the hierarchical 
decision-making contexts of many traditional hospitals, junior doctors often feel compelled to agree with their 
supervisors’  judgements48, and pharmacists may have less authority than medical  doctors49. In order to minimise 
this bias and maximise the benefits of WoC during ward rounds, health professionals’ judgements would there-
fore need to be collected individually and anonymously. Furthermore, whenever teams pre-commit to using the 
median prescription length as the group’s final judgement, then the robustness of the median (see the earlier 
discussion on this) prevents an unduly high influence of, say, one senior group member in a group together with 
two other, less senior group members.
10
Vol:.(1234567890)
Scientific Reports |        (2020) 10:18782  | https://doi.org/10.1038/s41598-020-75063-z
www.nature.com/scientificreports/
Multidisciplinary team meetings. Multidisciplinary team meetings refer to larger meetings of up to 10–15 dif-
ferent specialist doctors, nurses, pharmacists, and other health professionals. Given our findings of improved 
decision accuracy with increased group sizes, multidisciplinary team meetings are likely to yield the most reli-
able improvements of prescribing choices when using WoC. Additionally, the patient cases discussed during 
multidisciplinary team meetings might be most appropriate for WoC-based decision making. These typically 
include complex, long-term cases, where adequate evidence for the optimal duration of therapy is unavailable 
and existing guidelines fail to provide clear treatment recommendations. It is in those cases that the diverse 
experience of crowds could provide the most useful insights. To preserve such diversity at multidisciplinary 
team meetings, it is crucial to check the absence of institutional prescribing  biases46,50. Helpfully, hospitals and 
other health care institutions in many countries are characterised by frequent turnover of staff (particularly 
junior doctors) based on nationally regulated rotations of doctors. These regular changes in the composition of 
prescriber teams therefore guarantee some level of diversity.
To test feasibility and acceptability of WoC approaches in medical decision contexts, more applied research 
is necessary. Specifically, clinical intervention studies could help to evaluate the results of WoC-based decision 
procedures and trial technical tools (e.g., anonymous voting tools) to support the process.
Conclusions
Collecting and aggregating independent judgements of medical prescribers in line with the concept of the wis-
dom of crowds appears to be a promising decision technique to improve guideline compliance in the context 
of antibiotic decision making and reduce antibiotic overuse. Our simulation study provided evidence for the 
respective benefits of different group aggregation techniques to reduce inappropriate choices about antibiotic 
prescribing durations. Overall, using the median group judgement appears to yield the largest benefits. While 
decision accuracy increased with group size, improvements were found for groups as small as three prescribers. 
Follow-up research is necessary to explore the potential of collective decision making across a larger variety of 
prescriber samples and decision contexts. Real-life applicability needs to be tested and is likely to be greatest for 
hospital ward rounds and larger, multidisciplinary team meetings, where complex patient cases are discussed 
and existing guidelines provide limited guidance.
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